Hôpital Européen Georges Pompidou - AP-HP

56 currently recruiting clinical trials
Create patient profile for matching
Phase 2 / Phase 3 Stomach and esophageal cancer #NCT07221149 #2025-523263-37-00
Required histologic types
Stomach Oesogastric junction Esophagus
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required CPS scores
CPS Negative (< 1) CPS Positive (1 <= X < 5) CPS Positive (5 <= X < 10) CPS Positive (X >= 10)
Excluded genetic anomalies
HER2
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Bristol-Myers Squibb
Phase 2 / Phase 3 Colon cancer Rectal cancer #NCT05462613 #2024-516709-22-00
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Surgery Chemotherapy Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
CHU de Besançon
Phase 2 Head and neck cancer #NCT06769698 #2024-517620-19-00
Required histologic types
Oral cavity Oropharynx Hypopharynx Larynx
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required HPV statuses
HPV Positive HPV Negative
Required CPS scores
CPS Positive (1 <= X < 20) CPS Positive (X >= 20)
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Regeneron Pharmaceuticals
Phase 2 Breast cancer #NCT07007559
Required HER2 statuses
HER2 Positive
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Hôpital Européen Georges Pompidou - AP-HP (Paris)
ALX Oncologie Inc
Phase 2 Head and neck cancer #NCT05582122
Required histologic types
Oropharynx
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery Radiochemotherapy
Required P16 statuses
P16 Positive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
UNICANCER
Phase 2 Stomach and esophageal cancer #NCT05476796
Required histologic types
Stomach Oesogastric junction Esophagus
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required CPS scores
CPS Positive (1 <= X < 5) CPS Positive (5 <= X < 10) CPS Positive (X >= 10)
Excluded genetic anomalies
HER2
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
UNICANCER
Phase 2 Prostate cancer #NCT07005154 #2024-517653-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
None 1
Required previous treatments at advanced or metastatic stage
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Astellas Pharma Développement mondial, Inc.
Phase 2 Prostate cancer #NCT07005154 #2024-517653-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Astellas Pharma Développement mondial, Inc.
Phase 2 Stomach and esophageal cancer #NCT07205731
Required histologic types
Esophagus
Required histologic sub types
Squamous cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
CHU de Clermont-Ferrand
Phase 2 Rectal cancer #NCT04749108 #2021-000414-41
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Institut du Cancer de Montpellier - Val d'Aurelle